LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 10700

Search options

  1. Book ; Online ; E-Book: Fire ecology and management

    Greenberg, Cathryn H. / Collins, Beverly

    past, present, and future of US forested ecosystems

    (Managing Forest Ecosystems ; Volume 39)

    2021  

    Author's details Cathryn H. Greenberg, Beverly Collins, editors
    Series title Managing Forest Ecosystems ; Volume 39
    Keywords Forest fires/Environmental aspects ; Ecologia del foc ; Gestió forestal ; Estats Units d'Amèrica
    Subject code 634.9618
    Language English
    Size 1 online resource (513 pages)
    Publisher Springer
    Publishing place Cham, Switzerland
    Document type Book ; Online ; E-Book
    Remark Zugriff für angemeldete ZB MED-Nutzerinnen und -Nutzer
    ISBN 3-030-73267-3 ; 3-030-73266-5 ; 978-3-030-73267-7 ; 978-3-030-73266-0
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    Kategorien

  2. Article ; Online: Safety and Effectiveness of Probiotics in Preterm Infants with Necrotizing Enterocolitis.

    Calvo, Laura N / Greenberg, Rachel G / Gray, Keyaria D

    NeoReviews

    2024  Volume 25, Issue 4, Page(s) e193–e206

    Abstract: Although necrotizing enterocolitis is a leading cause of morbidity and mortality among preterm infants, its underlying pathophysiology is not fully understood. Gut dysbiosis, an imbalance between commensal and pathogenic microbes, in the preterm infant ... ...

    Abstract Although necrotizing enterocolitis is a leading cause of morbidity and mortality among preterm infants, its underlying pathophysiology is not fully understood. Gut dysbiosis, an imbalance between commensal and pathogenic microbes, in the preterm infant is likely a major contributor to the development of necrotizing enterocolitis. In this review, we will discuss the increasing use of probiotics in the NICU, an intervention aimed to mitigate alterations in the gut microbiome. We will review the existing evidence regarding the safety and effectiveness of probiotics, and their potential to reduce rates of necrotizing enterocolitis in preterm infants.
    MeSH term(s) Humans ; Infant, Newborn ; Enterocolitis, Necrotizing/prevention & control ; Infant, Premature ; Infant, Premature, Diseases/therapy ; Probiotics/adverse effects
    Language English
    Publishing date 2024-03-14
    Publishing country United States
    Document type Review ; Journal Article
    ISSN 1526-9906
    ISSN (online) 1526-9906
    DOI 10.1542/neo.25-4-e193
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Safety and Effectiveness of Probiotics in Preterm Infants with Necrotizing Enterocolitis.

    Calvo, Laura N / Greenberg, Rachel G / Gray, Keyaria D

    NeoReviews

    2024  Volume 25, Issue 4, Page(s) e193–e206

    Abstract: Although necrotizing enterocolitis is a leading cause of morbidity and mortality among preterm infants, its underlying pathophysiology is not fully understood. Gut dysbiosis, an imbalance between commensal and pathogenic microbes, in the preterm infant ... ...

    Abstract Although necrotizing enterocolitis is a leading cause of morbidity and mortality among preterm infants, its underlying pathophysiology is not fully understood. Gut dysbiosis, an imbalance between commensal and pathogenic microbes, in the preterm infant is likely a major contributor to the development of necrotizing enterocolitis. In this review, we will discuss the increasing use of probiotics in the NICU, an intervention aimed to mitigate alterations in the gut microbiome. We will review the existing evidence regarding the safety and effectiveness of probiotics, and their potential to reduce rates of necrotizing enterocolitis in preterm infants.
    MeSH term(s) Humans ; Infant, Newborn ; Enterocolitis, Necrotizing/prevention & control ; Infant, Premature ; Infant, Premature, Diseases/therapy ; Probiotics/adverse effects
    Language English
    Publishing date 2024-02-05
    Publishing country United States
    Document type Review ; Journal Article
    ISSN 1526-9906
    ISSN (online) 1526-9906
    DOI 10.1542/neo.25-3-e193
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Making the Most of Missing Data.

    Kilpatrick, Ryan / Greenberg, Rachel G

    Pediatrics

    2024  Volume 153, Issue 3

    MeSH term(s) Humans ; Infant, Newborn ; Models, Statistical ; Data Interpretation, Statistical
    Language English
    Publishing date 2024-02-22
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 207677-9
    ISSN 1098-4275 ; 0031-4005
    ISSN (online) 1098-4275
    ISSN 0031-4005
    DOI 10.1542/peds.2023-064938
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Alzheimer's & Dementia-Translational Research and Clinical Interventions

    Greenberg, Barry D

    Alzheimer's & dementia (New York, N. Y.)

    2022  Volume 8, Issue 1, Page(s) e12277

    Language English
    Publishing date 2022-03-15
    Publishing country United States
    Document type Editorial
    ZDB-ID 2832891-7
    ISSN 2352-8737 ; 2352-8737
    ISSN (online) 2352-8737
    ISSN 2352-8737
    DOI 10.1002/trc2.12277
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Bernard D. Goldstein-Risk communication as an essential component of public health practice.

    Burger, Joanna / Greenberg, Michael / Lowrie, Karen / Goldstein, Bernard D

    Risk analysis : an official publication of the Society for Risk Analysis

    2023  Volume 42, Issue 11, Page(s) 2459–2463

    MeSH term(s) Communication ; Public Health Practice ; Public Health
    Language English
    Publishing date 2023-01-09
    Publishing country United States
    Document type Editorial ; Research Support, U.S. Gov't, Non-P.H.S. ; Research Support, N.I.H., Extramural
    ZDB-ID 778660-8
    ISSN 1539-6924 ; 0272-4332
    ISSN (online) 1539-6924
    ISSN 0272-4332
    DOI 10.1111/risa.14055
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Gene Targeting Studies of Hyperexcitability and Affective States of Alcohol Withdrawal in Rodents.

    Greenberg, G D / Crabbe, J C

    International review of neurobiology

    2016  Volume 126, Page(s) 357–390

    Abstract: Genetically engineered rodents can be used to examine the influence of single genes on alcoholism-related phenotypes. We review studies that employed gene targeting with a focus on ethanol withdrawal-associated behaviors. Earlier studies targeted the ... ...

    Abstract Genetically engineered rodents can be used to examine the influence of single genes on alcoholism-related phenotypes. We review studies that employed gene targeting with a focus on ethanol withdrawal-associated behaviors. Earlier studies targeted the glutamate and GABA systems as contributors to the underlying hyperexcitable state of convulsions or similar signs of ethanol withdrawal. Over the past decade, many gene-targeting studies have continued to focus on the glutamatergic and GABAergic systems; however, an increasing number of these studies have focused on other withdrawal outcomes such as anxiety-like behavior and escalated ethanol consumption. Although negative affective states may drive escalated ethanol drinking, few reported studies examined the phenotypes together. However, there is significant overlap in the systems that were manipulated in relation to studying the phenotypes individually. These studies reveal common genetic influences on withdrawal-associated anxiety, convulsions, and escalated drinking that may contribute to relapse, setting the stage for the identification of novel medications to jointly target these effects.
    MeSH term(s) Alcoholism/complications ; Alcoholism/genetics ; Animals ; Animals, Genetically Modified ; Disease Models, Animal ; Epilepsy/genetics ; Gene Targeting/methods ; Hyperkinesis/etiology ; Mood Disorders/etiology ; Rodentia ; Substance Withdrawal Syndrome/complications ; Substance Withdrawal Syndrome/genetics ; gamma-Aminobutyric Acid/genetics ; gamma-Aminobutyric Acid/metabolism
    Chemical Substances gamma-Aminobutyric Acid (56-12-2)
    Language English
    Publishing date 2016
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S. ; Review
    ZDB-ID 209876-3
    ISSN 2162-5514 ; 0074-7742
    ISSN (online) 2162-5514
    ISSN 0074-7742
    DOI 10.1016/bs.irn.2016.02.010
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Placebo response rate is ruining drug development in psychiatry: why is this happening and what can we do about it?

    Stahl, Stephen M / Greenberg, Gian D

    Acta psychiatrica Scandinavica

    2019  Volume 139, Issue 2, Page(s) 105–107

    MeSH term(s) Adolescent ; Drug Development ; Humans ; Placebo Effect ; Psychiatry ; Schizophrenia
    Language English
    Publishing date 2019-01-24
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 103-x
    ISSN 1600-0447 ; 0001-690X
    ISSN (online) 1600-0447
    ISSN 0001-690X
    DOI 10.1111/acps.13000
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Book ; Online: Directors as Guardians of Compliance and Ethics Within the Corporate Citadel

    Greenberg, Michael D

    What the Policy Community Should Know

    2010  

    Keywords Business strategy ; Company, commercial & competition law ; Law ; Business
    Language English
    Size 1 Online-Ressource
    Publisher RAND Corporation
    Document type Book ; Online
    Note English
    HBZ-ID HT030609985
    ISBN 9780833050328 ; 083305032X
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    More links

    Kategorien

  10. Article ; Online: Lecanemab: Appropriate Use Recommendations.

    Cummings, J / Apostolova, L / Rabinovici, G D / Atri, A / Aisen, P / Greenberg, S / Hendrix, S / Selkoe, D / Weiner, M / Petersen, R C / Salloway, S

    The journal of prevention of Alzheimer's disease

    2023  Volume 10, Issue 3, Page(s) 362–377

    Abstract: Lecanemab (Leqembi®) is approved in the United States for the treatment of Alzheimer's disease (AD) to be initiated in early AD (mild cognitive impairment [MCI] due to AD or mild AD dementia) with confirmed brain amyloid pathology. Appropriate Use ... ...

    Abstract Lecanemab (Leqembi®) is approved in the United States for the treatment of Alzheimer's disease (AD) to be initiated in early AD (mild cognitive impairment [MCI] due to AD or mild AD dementia) with confirmed brain amyloid pathology. Appropriate Use Recommendations (AURs) are intended to help guide the introduction of new therapies into real-world clinical practice. Community dwelling patients with AD differ from those participating in clinical trials. Administration of lecanemab at clinical trial sites by individuals experienced with monoclonal antibody therapy also differs from the community clinic-based administration of lecanemab. These AURs use clinical trial data as well as research and care information regarding AD to help clinicians administer lecanemab with optimal safety and opportunity for effectiveness. Safety and efficacy of lecanemab are known only for patients like those participating in the phase 2 and phase 3 lecanemab trials, and these AURs adhere closely to the inclusion and exclusion criteria of the trials. Adverse events may occur with lecanemab including amyloid related imaging abnormalities (ARIA) and infusion reactions. Monitoring guidelines for these events are detailed in this AUR. Most ARIA with lecanemab is asymptomatic, but a few cases are serious or, very rarely, fatal. Microhemorrhages and rare macrohemorrhages may occur in patients receiving lecanemab. Anticoagulation increases the risk of hemorrhage, and the AUR recommends that patients requiring anticoagulants not receive lecanemab until more data regarding this interaction are available. Patients who are apolipoprotein E ε4 (APOE4) gene carriers, especially APOE4 homozygotes, are at higher risk for ARIA, and the AUR recommends APOE genotyping to better inform risk discussions with patients who are lecanemab candidates. Clinician and institutional preparedness are mandatory for use of lecanemab, and protocols for management of serious events should be developed and implemented. Communication between clinicians and therapy candidates or those on therapy is a key element of good clinical practice for the use of lecanemab. Patients and their care partners must understand the potential benefits, the potential harms, and the monitoring requirements for treatment with this agent. Culture-specific communication and building of trust between clinicians and patients are the foundation for successful use of lecanemab.
    MeSH term(s) Humans ; Apolipoprotein E4/genetics ; Alzheimer Disease/genetics ; Antibodies, Monoclonal/therapeutic use ; Amyloid
    Chemical Substances Apolipoprotein E4 ; lecanemab (12PYH0FTU9) ; Antibodies, Monoclonal ; Amyloid
    Language English
    Publishing date 2023-06-14
    Publishing country Switzerland
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2782183-3
    ISSN 2426-0266 ; 2274-5807
    ISSN (online) 2426-0266
    ISSN 2274-5807
    DOI 10.14283/jpad.2023.30
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top